Home

Glenmark Pharmaceuticals Ltd PE Ratio

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

PE

-

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Glenmark Pharmaceuticals Ltd is 0 as of 15 Jan 13:30 PM .
  • The P/E Ratio of Glenmark Pharmaceuticals Ltd changed from 7.5 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Latest Trading Price of Glenmark Pharmaceuticals Ltd is ₹ 1463 as of 15 Jan 13:23 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Glenmark Pharmaceuticals Ltd

No data available

Company Fundamentals for Glenmark Pharmaceuticals Ltd

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

Share Price

₹ 1463.3

-51.65 (-3.41%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Glenmark Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20251514.95
13 Jan 20251497.65
10 Jan 20251540.7
09 Jan 20251592.9
08 Jan 20251626.55
07 Jan 20251641.55
06 Jan 20251622.4
03 Jan 20251636.05
02 Jan 20251638.95
01 Jan 20251614.05

SWOT Analysis Of Glenmark Pharmaceuticals Ltd

Strength

4

che

Weakness

2

che

Opportunity

1

che

Threats

1

che

BlinkX Score for Glenmark Pharmaceuticals Ltd

Asset Value vs Market Value of Glenmark Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Glenmark Pharmaceuticals Ltd42750
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Glenmark Pharmaceuticals Ltd Explained

``

42750

Market cap

-875

Earnings

0.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Glenmark Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Glenmark Pharmaceuticals Ltd

No data available

* All values are in %

About Glenmark Pharmaceuticals Ltd

  • Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977.
  • The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
  • It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
  • Its branded generics business has a significant presence in markets across emerging economies including India.
  • The company has 14 manufacturing facilities across US, India, Argentina, Czech Republic and Switzerland.

Glenmark Pharmaceuticals Ltd News Hub

Glenmark Pharmaceuticals Ltd spurts 2.5%, rises for fifth straight session

Glenmark Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 1

Read more

2024-08-21 00:00:00

Glenmark Pharmaceuticals Ltd soars 4.33%, rises for third straight session

Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 163

Read more

2024-08-19 00:00:00

Glenmark Pharma gains after American subsidiary launches Olopatadine generic

The solution is the generic version of 'Pataday Twice Daily Relief', which is distributed by Alcon L

Read more

2024-08-19 00:00:00

Glenmark launches Olopatadine Hydrochloride Ophthalmic Solution

Glenmark Therapeutics Inc., USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalmic Solutio

Read more

2024-08-19 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Glenmark Pharmaceuticals Ltd

What is the current PE Ratio of Glenmark Pharmaceuticals Ltd?

The Current PE Ratio of Glenmark Pharmaceuticals Ltd is 0.0 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Glenmark Pharmaceuticals Ltd last year?

The PE Ratio of Glenmark Pharmaceuticals Ltd was 44.16 last year, now the PE ratio is 0.0, showing a year-on-year growth of -100.0%.

What does the PE Ratio of Glenmark Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Glenmark Pharmaceuticals Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Glenmark Pharmaceuticals Ltd.

What is the PE Ratio Growth of Glenmark Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Glenmark Pharmaceuticals Ltd grew by -100.0% whereas, the EPS ratio grew by 4.1.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions